Best of 2025: Top 10 Insights in Clinical Trial Technology

#1 - Wearables: An Essential For Decentralized Clinical Trials

Bryan Hansen, Ph.D., director of Innovative Health at Johnson & Johnson Innovative Medicine, discusses types of wearables, his experience using them in neurological disease clinical trials, and some future plans for these devices.

#2 - Why Aren't We Using More Wearables In Clinical Trials?

Wearables provide a great means for passive data collection in clinical trials, but implementing them isn’t as easy at it seems. Lauren Sunshine, director, product management, digital health, at BMS, talks about some of the advantages — and challenges — of incorporating DHTs into your trial protocols.

#3 - The Future Of AI In Clinical Research, Delivered Today

The FDA's new guidance outlines a future where AI models support regulatory submissions, taking a pivotal step toward modernizing regulatory science.

#4 - Bring Your Own Device (BYOD) Clinical Trials: How They Transform Decentralized Data Capture

Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data

#5 - eClinical Solutions Market To Double In 5 Years, As Sponsors Prioritize Efficiency

The global eClinical solutions market is projected to reach $22.1 billion in 2029, double its presence in 2024. Experts discuss the specific solutions driving market growth and share how they impact clinical operations.

#6 - Is Double Programming Really Required For Validation?

Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.

#7 - Why Is Trust Stifling Our RBM Implementations?

It’s one thing to implement RBM (risk-based monitoring) components like central monitoring or initial risk assessments, but if you’re still doing 100% SDR/SDV, you’re not maximizing the benefits of this approach. So what’s the holdup?

#8 - From Detection To Decision: Accelerating Clinical Data Review With Traceable Workflows

Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

#9 - What's The Deal With eConsent?

Are you for or against eConsent? It’s odd that this technology has kind of become a polarizing topic in the clinical trials industry. To find out why, I decided to get some feedback from folks who have actually used it.

#10 - 3 FDA Guidance Documents That Shaped Today's Computer System Validation

Dan Schell, chief editor of Clinical Leader, sat down with an expert panel to discuss what technologies have been most beneficial to clinical sites, as well as some of the barriers to adoption.